Another offering for Avidity; Galera shuts down
Plus, news about Kezar Life Sciences, Elicio Therapeutics and Viracta Therapeutics:
Avidity seeks $250M in public offering: The money will be used in part to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.